Guidelines Comparison•Urology
NCCN vs. SNMMI vs. ASCO vs. AUA Guidelines for Prostate Cancer and PSMA-PET Imaging
NCCNSNMMIASCOAUA
What it covers
All four organizations broadly agree on which patients should be considered for PSMA-PET, but they differ in emphasis, how central PSMA-PET is to the workup, and how current each document is.
This comparison covers the role of PSMA-PET in the NCCN Prostate Cancer guidelines, what’s new in 2026, and how NCCN, SNMMI, ASCO and AUA guidance compare side by side.
Questions about PSMA PET/CT for your practice? Request a consultation with the MIS team.
This material was developed by Molecular Imaging Services for educational purposes and is not sponsored or endorsed by any product manufacturer. Pluvicto and Pylarify are trademarks of their respective owners.
